Option 8: Tumor Necrosis Factor Inhibitors
Tumor necrosis factor (TNF) inhibitors are a class of biologic medications that target a specific protein involved in the inflammatory process of RA. By blocking the action of TNF, these medications can help reduce inflammation, alleviate symptoms, and slow the progression of joint damage.
Examples of TNF inhibitors include etanercept, infliximab, adalimumab, golimumab, and certolizumab pegol. These medications are typically administered through subcutaneous injection or intravenous infusion, depending on the specific drug and dosage.
TNF inhibitors can be highly effective in treating RA, particularly in patients who have not responded adequately to traditional DMARDs. However, these medications can also increase the risk of infections and other side effects. It’s important to work closely with your healthcare provider to monitor for potential side effects and ensure the medication is working effectively. (8)
